Kristin Luther

Company: Vesigen Therapeutics

Job title: Associate Director- Downstream Process Development

Seminars:

Scalable Production & Characterization of Non- Immunogenic ARMMs Particles 12:00 pm

Using scalable, GMP-compliant processes, we can produce ARMMs efficiently payloaded with biomolecules of interest such as gene editors. ARMMs in vivo: how the route of administration affects biodistribution and the specific cell types which take up ARMMs Repeated administration in immunocompetent mice is safe, supporting their use as a non-viral delivery methodRead more

day: Day 2 Track B – AM